F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus

NCT06468683 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Erythematosis

Interventions

BIOLOGICAL: After preconditioning with chemotherapy, F01 will be evaluated.

Sponsor

Shanghai Simnova Biotechnology Co.,Ltd.